AI Terminal

MODULE: AI_ANALYST
Interactive Q&A, Risk Assessment, Summarization
MODULE: DATA_EXTRACT
Excel Export, XBRL Parsing, Table Digitization
MODULE: PEER_COMP
Sector Benchmarking, Sentiment Analysis
SYSTEM ACCESS LOCKED
Authenticate / Register Log In

INTELLIGENT ULTRASOUND GROUP PLC

AGM Information Aug 27, 2019

7714_dva_2019-08-27_e34bbdf6-4906-4da1-bd23-f6b5bdfcc816.html

AGM Information

Open in Viewer

Opens in native device viewer

National Storage Mechanism | Additional information

You don't have Javascript enabled. For full functionality this page requires javascript to be enabled.

RNS Number : 2768K

Intelligent Ultrasound Group PLC

27 August 2019

27 August 2019

Intelligent Ultrasound Group plc

("Intelligent Ultrasound" or the "Company")

Results of General Meeting, Open Offer and Total Voting Rights

Intelligent Ultrasound (AIM: MED), the intelligent ultrasound software and simulation company, is pleased to announce that at the General Meeting held earlier today, all resolutions proposed were duly passed by shareholders.  Details of the votes cast by proxy will be published on the Company's website shortly.

Furthermore, the Open Offer closed for acceptances at 11.00 a.m. on 23 August 2019 with final valid applications from Qualifying Shareholders in respect of 869,043 Open Offer Shares including applications under the Excess Application Facility, representing a take-up of approximately 34.7 per cent. of the Open Offer Shares.

Accordingly, the Company will raise a total of approximately £6.3 million (before expenses) through the Placing and Open Offer through the issue and allotment of 63,369,043 new Ordinary Shares. An application has been made for 63,369,043 new Ordinary Shares to be admitted to trading on AIM, which is expected to take place at 8.00 a.m. on 28 August 2019.

Following Admission, the Company's issued share capital will comprise 219,996,792 Ordinary Shares, of which none are held in treasury. The above figure of 219,996,792 may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the voting rights of the Company under the FCA's Disclosure Guidance and Transparency Rules.

Unless otherwise defined herein, capitalised terms used in this announcement shall have the same meanings as defined in the circular sent to shareholders of the Company on 8 August 2019.

Enquiries:

Intelligent Ultrasound Group plc www.intelligentultrasound.com
Stuart Gall, CEO Tel: +44 (0)29 2075 6534
Cenkos Securities Tel:  +44 (0)20 7397 8900
Giles Balleny/Cameron MacRitchie (Nominated Adviser)
Michael Johnson/Julian Morse (Corporate Broking)
Walbrook PR Tel: +44 (0)20 7933 8780

or [email protected]
Anna Dunphy/Paul McManus Mob: +44 (0)7876 741 001/Mob: +44 (0)7980 541 893

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

END

ROMPRMMTMBITBJL

Talk to a Data Expert

Have a question? We'll get back to you promptly.